Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis.
- DOI
- 10.5217/ir.2025.00338
- Published
- 2026 Aug 10
- Container
- Intestinal research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5217/ir.2025.00338,
title = {Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis.},
author = {Morikawa R and Fujii T and Tamura A and Kawamoto A and Hibiya S and Takenaka K and Shimizu H and Ohtsuka K and Okamoto R},
year = {2026},
journal = {Intestinal research},
doi = {10.5217/ir.2025.00338},
url = {https://doi.org/10.5217/ir.2025.00338}
}RIS
TY - JOUR TI - Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis. AU - Morikawa R AU - Fujii T AU - Tamura A AU - Kawamoto A AU - Hibiya S AU - Takenaka K AU - Shimizu H AU - Ohtsuka K AU - Okamoto R PY - 2026 JO - Intestinal research DO - 10.5217/ir.2025.00338 UR - https://doi.org/10.5217/ir.2025.00338 ER -
APA
R, M., T, F., A, T., A, K., S, H., K, T., H, S., K, O., & R, O. (2026). Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis.. Intestinal research. https://doi.org/10.5217/ir.2025.00338
Source records
- pubmed · retrieved 2026-09-25T09:24:40.771Z